Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CEC levels may be a useful marker for predicting prostate cancer progression.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Alopecia areata in infants may be more common than previously thought.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Gene variation affects prostate issues and hair loss.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Long-lived proteins may predict age-related diseases.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The document concludes that Hilary Mantel's memoir shows how childhood experiences affect adult health, criticizing modern medicine for ignoring the mental aspects of physical illness.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

The document reports the first case of a rare skin condition in Colombia, the 19th case worldwide.

Growth hormone therapy can improve growth in Netherton syndrome patients with growth hormone deficiency.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

NISCH syndrome is a rare genetic disorder affecting skin and liver, with variable symptoms and limited treatment options.